<DOC>
	<DOCNO>NCT02124564</DOCNO>
	<brief_summary>This study evaluate long-term safety tolerability Lacosamide ( LCM ) 200 mg/day LCM 600 mg/day take monotherapy Japanese subject currently partial-onset seizure without secondary generalization treat single Anti-Epileptic Drug ( AED ) marketing approval Japan .</brief_summary>
	<brief_title>A Trial Evaluate Long Term Safety Tolerability Lacosamide Taken Monotherapy Adults With Partial-onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Lacosamide</mesh_term>
	<criteria>Subject male female â‰¥16 year age Subject diagnosis epilepsy , experience unprovoked partialonset seizure ( IA , IB , IC clear focal origin ) classifiable accord International League Against Epilepsy ( ILAE ) Classification Epileptic Seizures , 1981 Subject experience partialonset seizures despite appropriately choose adequately tried treatment 1 antiepileptic drug ( AED ) Subject treat epilepsy stable dose 1 market AED The use benzodiazepine permit rescue therapy epilepsy . Benzodiazepines may use need frequently per week . Subject history presence seizures type partial onset ( IA , IB , IC clear focal origin ) Subject take benzodiazepine nonepilepsy indication ( Exception : Concomitant use benzodiazepine allow subject take regular basis , stable dose least 1 month prior Visit 1 , require change dosage administration throughout study period . However , concomitant use benzodiazepine need basis permit . ) Female subject pregnant nursing , and/or woman childbearing potential surgically sterile , 2 year postmenopausal practice 1 highly effective method contraception , unless sexually abstinent , duration study Female subject childbearing potential take enzymeinducing antiepileptic drug ( EIAEDs : CBZ , phenytoin , barbiturate , primidone , topiramate ) surgically sterile , 2 year postmenopausal practice 1 highly effective method contraception accord World Health Organization ( WHO ) recommendation ( ie , depot medroxyprogesterone acetate , norethisterone enantate , intrauterine device , combine injectables , progestogen implant ) administration EIAEDs practice 2 combine method contraception ( ie , combine hormonal contraception plus barrier method spermicidal agent ) , unless sexually abstinent , duration study Subject sick sinus syndrome without pacemaker , second third degree atrioventricular ( AV ) block , subject clinically relevant electrocardiogram ( ECG ) abnormality Subject history convulsive status epilepticus within last 12 month prior Visit 1</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Lacosamide</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Focal , Partial-Onset Seizures without secondary generalization</keyword>
	<keyword>Monotherapy</keyword>
</DOC>